Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Market
By 2032, the magnetic resonance imaging (MRI) robot-assisted surgeries market share was estimated to be worth USD 6.02 billion, growing at a CAGR of 13.9%. The benefits of robot-assisted surgery, the rise in surgical procedures, the expansion of funding for surgical robots' research, and better reimbursement policies are all considered to be driving factors in the growth of this market. The popularity of MRI robot-assisted surgeries is further rising due to the increasing acceptance and acceptance of minimally-invasive surgeries (MIS). This results from shorter hospital stays, faster healing, smaller small cuts, less pain and scarring, and increased accuracy. Since MRI robots are entirely based on MIS, these advantages have increased demand for MRI robot-assisted surgeries. Currently, prostate biopsies are the main application for the robot system with MRI compatibility. Two prostate cancer treatment options accepted as normal by patients are transrectal and transperineal interventions.
In addition, this market is anticipated to have better growth opportunities due to the growing prevalence of surgical robots in ambulatory surgery facilities (ASCs) and emerging markets. Additionally, it provides an entirely intuitive user interface for making process plans, enabling robotic alignment and anatomical mapping of the patient using a scanner. Additionally, the growing incidence of cancer worldwide is helping the market expand. Furthermore, the techniques used by magnetic resonance imaging (MRI) robots are well tolerated by cancer patients. As doctors become more adept at using the MRI-assisted robot, procedure time and MRI time shortening, increasing procedure room efficiency will further benefit the market's growth.
Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Market Outlook and Analysis by Product (Sensors, Actuators, and Robots), By Application (Oncology Surgery (Prostate Biopsy & Brachytherapy, Brain Biopsy & Intervention, Breast Cancer Diagnosis & Intervention, and Liver Cancer Diagnosis & Intervention), Neurological Surgery, and Cardiovascular Surgery), By End User (Hospitals, Ambulatory Research Centers, and Specialty Clinics) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032.
Major Key Players:
The support of governments around the world for market-friendly changes is evident. Throughout the projection period, there will be an increase in the number of sales and marketing operations conducted online. The involvement of acquisitions and applications is expected to become increasingly important in the coming period to maintain development speed. As a result of the global epidemic, institutions now have a strong mandate for the purchasing process and a quickening of digital transformation. It will be advanced by using thorough research techniques to track the market's future expansion. During the projection period, significant players are anticipated to inject cash into the market, which is anticipated to accelerate market growth further. In the upcoming years, trade associations are expected to grow, expanding the global market. As more products are introduced to the market to meet the shifting needs of various clientele, the market is expected to expand.
The Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Market Players are AiM Medical Robotics (U.S.), Monteris Medical (Canada), Machnet Medical Robotics B.V (Netherlands), neuro42, Inc. (U.S.), IMRIS (Canada), ACCURAY INCORPORATED (U.S.), and Stereotaxis Inc. (U.S.)
Segment Analysis
Oncology, neurological, and cardiovascular surgery are included in the segmentation of the magnetic resonance imaging (MRI) robot-assisted surgeries market based on application. Actuators, sensors, and robots are included in the magnetic resonance imaging (MRI) robot-assisted surgeries market segmentation based on product. Hospitals, ambulatory surgical centers, and specialty clinics comprise the three main subgroups of the global magnetic resonance imaging (MRI) robot-assisted surgery market.
Regional Analysis
Due to the widespread use of MRI-assisted robots and the rising number of procedures due to the high cancer rates, North America held the largest market share for MRI robot-assisted surgeries in 2022. The substantial market share held by North America is primarily attributable to the developed healthcare systems in the United States and Canada, the accessibility of qualified medical personnel, and the growing preference of surgical professionals for cutting-edge surgical systems. Due to technological advancements, rising healthcare costs, and an increase in neurological and cardiovascular diseases, Europe took second place in market share for robot-assisted MRI surgeries. Due to the region's rising cancer incidence and aging population, the market for robotically assisted magnetic resonance imaging (MRI) surgeries is anticipated to expand significantly between 2023 and 2030.
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312